Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 14, 2024 4 months, 1 week, 4 days, 7 hours, 7 minutes ago
Medical News: In a groundbreaking study, researchers from Nelson Laboratories Bozeman, LLC, Montana-USA and Innovotech, Inc., Edmonton-Canada have discovered that a unique silver compound, pentasilver hexaoxoiodate (Ag5IO6), exhibits potent antiviral activity against several significant viruses, including SARS-CoV-2. This finding covered in this
Medical News report, could pave the way for new treatments and preventative measures against viral infections, especially in the era of antibiotic resistance.
New Silver Compound Shows Promise in Fighting Deadly Viruses
The Growing Threat of Antimicrobial Resistance
Antimicrobial resistance (AMR) is a growing public health crisis, threatening the effectiveness of existing treatments for infections caused by bacteria, fungi, viruses, and parasites. Traditional antibiotics often fall short due to the rise of resistant strains, creating an urgent need for alternative solutions. Silver-based products have long been recognized for their antimicrobial properties, but their clinical use has been limited by several factors, including rapid inactivation by bodily fluids and challenges in incorporating them into medical devices.
Ag5IO6: A Versatile Antimicrobial Agent
Ag5IO6, originally developed for electrochemical applications, has shown remarkable efficacy against a broad spectrum of microorganisms, including biofilms and planktonic bacteria. Unlike other silver compounds, Ag5IO6 remains active in the presence of bodily fluids and exhibits slow, sustained release, making it ideal for medical applications. This compound is composed of nanoscale grains forming polycrystalline microscale particles, enhancing its stability and effectiveness.
Testing Ag5IO6 Against Viruses
The recent study aimed to evaluate the antiviral properties of Ag5IO6 against a range of viruses: adenovirus type 5, murine norovirus, poliovirus type 1, and two strains of SARS-CoV-2 (original and omicron). The compound's efficacy was tested using the ASTM E1052-20 standard, which assesses the activity of microbicides against viruses in suspension. Ag5IO6 was prepared as a 0.1 g/mL suspension and exposed to the viruses for varying durations (30 minutes, 4 hours, and 24 hours).
Promising Results Against SARS-CoV-2 and Norovirus
The results were striking. Ag5IO6 achieved complete inactivation of the omicron strain of SARS-CoV-2 within 30 minutes and the original strain within 4 hours. Additionally, it completely eliminated murine norovirus within 4 hours. However, the compound showed limited activity against adenovirus type 5 and no activity against poliovirus type 1. These findings highlight Ag5IO6's potential as a broad-spectrum antiviral agent, particularly against enveloped viruses like SARS-CoV-2.
Potential Mechanisms of Action
The antiviral activity of Ag5IO6 is believed to stem from its ability to release both cationic and anionic silver species, which disrupt viral proteins and inhibit viral replication. The inclusion of iodine
in the compound may further enhance its efficacy, as certain forms of iodine are known to possess virucidal properties. The compound's ability to target multiple viral components reduces the likelihood of resistance development, a significant advantage in the ongoing battle against viral infections.
Implications for Medical Device Coatings and High-Touch Surfaces
The demonstrated antiviral activity of Ag5IO6 suggests it could be a valuable addition to coatings for medical devices and high-touch surfaces, offering long-term protection against viral transmission. This could be particularly beneficial in healthcare settings, where hospital-acquired infections pose a significant risk. Incorporating Ag5IO6 into wound dressings, air filters, and other medical products could help reduce the spread of infections and improve patient outcomes.
Addressing the Limitations
While Ag5IO6 shows great promise, there are some limitations to its use. The compound's dark brown color may restrict its application in certain settings, and its low solubility and density could pose challenges for liquid applications. Further research and development are needed to optimize the compound's formulation and delivery methods for various applications.
Conclusion
The discovery of Ag5IO6's antiviral properties marks a significant advancement in the fight against viral infections. As the world continues to grapple with the COVID-19 pandemic and other emerging viral threats, innovative solutions like Ag5IO6 offer hope for more effective treatments and preventative measures. Future research will focus on expanding the compound's applications and exploring its full potential in combating a wide range of viruses. This versatile silver compound could play a crucial role in reducing the burden of viral infections and improving global public health.
The study findings were published in the peer reviewed journal: Viruses.
https://www.mdpi.com/1999-4915/16/6/959
For the latest about pentasilver hexaoxoiodate as an antiviral agent, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/pharma-news-thailand-medical-news-calls-for-urgent-research-of-incorporating-silver-nanoparticles-to-existing-antivirals-to-treat-covid-19-and-h5n1
https://www.thailandmedical.news/news/covid-19-protection-new-protective-plastic-film-containing-silver-silica-nanoparticles-eliminates-99-84-percent-of-sars-cov-2-virus-on-contact-
Share
Tweet
Share
